From: Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
Compound
Plaque Reduction EC50 (μM)
Luciferase
EC50 (μM)
Reference
FOS
328 +/- 28
268 +/- 20
[28]
Dimer Sulfone Carbamate
0.067 +/- 0.011
0.066 +/- 0.004
[18]
ART
8.03 +/- 0.55
6.74 +/- 0.38
[29]
GCV
4.39 +/- 0.39
4.23 +/- 0.27
[30]
CHX
0.262 +/- 0.067
0.299 +/- 0.036
NA